Answers are grounded in this paper and cite their sources.
Two thousand, one hundred and seventy-three patients with cancer or chronic infections were treated with coumarin in a clinical trial. 2. 0.37% of these patients developed elevated liver enzyme levels during therapy with coumarin. 3. This hepatitis was probably a form of idiosyncratic hepatotoxicity and may have been immune in origin.
No takes yet. Share an insight, caveat, or question.
Cox et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: